Abbott has received approval from the US Food and Drug Administration (FDA) for its iDesign Advanced WaveScan Studio System.
Said to act as the brain of the laser assisted in situ keratomileusis (LASIK) procedure, the system generates a high-definition scan, which measures and maps irregularities of the eye that may impact vision.
These measurements will allow the system to create an accurate and personalized LASIK treatment plan based on the unique blueprint of each person’s eyes.
The system captures around 1,200 micro readings of the eye, as well as identifies shape of the cornea, its curvature and how light passes through the eye and pupil diameter under different lighting conditions.
Abbott’s vision business research and development head Leonard Borrmann said: "The iDesign System for LASIK is a leap forward for laser vision correction in the US, enabling a highly personalized treatment unique to the vision needs of each person.
"The same technology used to help build NASA’s new James Webb Space Telescope, which will allow high-definition views of space, is allowing us to map the human eye with great precision."
The iDesign system allows doctors to treat higher levels of astigmatism in people with nearsightedness, wider range of pupil sizes and people with 18 years of age and older.
Since 2012, the iDesign system received approval in different countries across the globe, including China and the European Union.
Image: The FDA has approved Abbott’s iDesign Advanced WaveScan Studio system. Photo: courtesy of Abbott Laboratories.